Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Mangoceuticals Inc

MGRX ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Healthcare Facilities & Services ·

USA Micro Cap Analyst: N/A

Last Close

$0.53

▲ +0.23%

Market Cap $11.53M · Vol 1.11M

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$11.53M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

49.60

Momentum

Beta

2.24

vs Market

52W High

$2.74

80.50% below

52W Low

$0.16

229.88% above

Volume

1.11M

Avg 1.12M

P/B

0.77

Price-to-book

ROE

N/A

Return on equity

Free Float

92.01%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Mangoceuticals Inc (MGRX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does MGRX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+8.60%

+36.54%

+35.95%

+34.95%

YTD

-27.78%

-66.18%

-96.73%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$456.02K
Net Income	$-20,643,460.00
Revenue Growth (YoY)	-59.10%
Gross Margin	-191.27%
Operating Margin	-4,200.46%
Net Profit Margin	-4,526.86%
ROE	N/A
ROA · ROIC	-131.24% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	16.34
P/B	0.77
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	21.57M

Technical Indicators

50-Day SMA	$0.43
200-Day SMA	$0.63
RSI (14)	49.60
Beta	2.24
52-Week High	$2.74
52-Week Low	$0.16

Volume Today	1.11M
Avg Daily Volume (30D)	1.12M
Relative Volume	0.99x
Volatility (10D)	177.13
Volatility (30D)	291.33
Free Float	92.01%

Analyst Consensus

N/A

Current Price $0.53

Mean Target N/A

52W Low$0.16 52W High$2.74

Current

Target

$0.16 $2.74

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG01CCMRBK4

ISINUS56270V2051

CountryUnited States of America

Sub-IndustryHealthcare Facilities & Services (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

FRE.DE Fresenius SE & Co KGaA -1.22% DGX Quest Diagnostics Inc -0.69% 4013.SE Dr Sulaiman Al Habib Medical Services Group Company SJSC -1.64% MAXHEALTH.NS Max Healthcare Institute Ltd -0.46% UHS Universal Health Services Inc -0.70%

Company Profile

Mangoceuticals, Inc. is focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx and is also focused on wellness solutions. It is advancing its proprietary antiviral compound MGX-0024. The Company offers pharmaceutical-based products specifically related to the treatments of erectile dysfunction (ED), hair growth, hormone replacement therapies, and weight management. It has developed and is commercially marketing a brand of ED products under the brand name Mango; a brand of hair loss products under the brand name Grow; a brand of hormone balance and therapy products under the name Mojo, and a brand of weight loss products under the brand name Slim. Prime by MangoRx is a TRT product available by prescription. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin.